Dawei Huo
Impact in
-
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- RNA modifications and cancer
- Genomics and Chromatin Dynamics
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
- CRISPR and Genetic Engineering
Papers in
-
- Epigenetics and DNA Methylation 11
- Genomics and Chromatin Dynamics 6
- Cancer-related gene regulation 5
- Pluripotent Stem Cells Research 3
- CRISPR and Genetic Engineering 2
-
- Macrophage Migration Inhibitory Factor 2
- Galectins and Cancer Biology 2
- Co-authors
- Xudong Wu (13 shared papers)Yan Zhou (3 shared papers)Yu Kong (4 shared papers)Chenghao Xuan (3 shared papers)Chunsheng Kang (2 shared papers)Xiaoyu Sun (2 shared papers)Weiwei Gao (1 shared paper)Chao Yang (1 shared paper)
- Journals
- Nature Communications (2 papers)Advanced Science (2 papers)Molecular Cell (2 papers)Theranostics (1 paper)Journal of Hematology & Oncology (1 paper)
- Partner nations
- ChinaDenmarkUnited States
In The Last Decade
Dawei Huo
24 papers receiving 456 citations
Peers
Comparison fields: 5 of 57
- Molecular Biology 312
- Cancer Research 40
- Oncology 56
- Cell Biology 32
- Immunology 38
Countries citing papers authored by Dawei Huo
This map shows the geographic impact of Dawei Huo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Huo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Huo more than expected).
Fields of papers citing papers by Dawei Huo
This network shows the impact of papers produced by Dawei Huo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Huo. The network helps show where Dawei Huo may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Huo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 100 | |
| 2 | 2016 | 57 | |
| 3 | 2021 | 34 | |
| 4 | 2021 | 28 | |
| 5 | 2022 | 24 | |
| 6 | 2025 | 23 | |
| 7 | 2020 | 22 | |
| 8 | 2016 | 21 | |
| 9 | 2023 | 21 | |
| 10 | 2021 | 20 | |
| 11 | 2019 | 20 | |
| 12 | 2022 | 19 | |
| 13 | 2024 | 18 | |
| 14 | 2021 | 13 | |
| 15 | 2025 | 11 | |
| 16 | 2025 | 7 | |
| 17 | 2020 | 7 | |
| 18 | 2023 | 7 | |
| 19 | 2025 | 3 | |
| 20 | 2024 | 2 |
About Dawei Huo
Dawei Huo is a scholar working on Molecular Biology, Immunology, Oncology, Cell Biology and Developmental Neuroscience, having authored 28 papers that have together received 461 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (11 papers), Genomics and Chromatin Dynamics (6 papers), Cancer-related gene regulation (5 papers), Pluripotent Stem Cells Research (3 papers), CRISPR and Genetic Engineering (2 papers), CAR-T cell therapy research (2 papers), Macrophage Migration Inhibitory Factor (2 papers) and Galectins and Cancer Biology (2 papers). The work is most often cited by research in Molecular Biology (312 citations), Cancer Research (40 citations), Oncology (56 citations), Cell Biology (32 citations) and Immunology (38 citations). Dawei Huo has collaborated with scholars based in China, Denmark and United States. Frequent co-authors include Xudong Wu, Yan Zhou, Yu Kong, Chenghao Xuan, Chunsheng Kang, Xiaoyu Sun, Weiwei Gao, Chao Yang, Wen Wang and Wei Li. Their work appears in journals such as Nature Communications, Advanced Science, Molecular Cell, Theranostics and Journal of Hematology & Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.